Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...
Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...
Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...
John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...
Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...
Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...
ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...
Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...
Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...
Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.09 | 3.57846355877 | 30.46 | 33.09 | 27.15 | 6748 | 28.91900714 | CS |
4 | 0.39 | 1.25160462131 | 31.16 | 34.6 | 27.15 | 4578 | 30.91492183 | CS |
12 | -6.89 | -17.924037461 | 38.44 | 44.64 | 27.15 | 3463 | 33.52745314 | CS |
26 | -4.33 | -12.0680044593 | 35.88 | 44.64 | 27.15 | 5493 | 34.50607706 | CS |
52 | 4.99 | 18.7876506024 | 26.56 | 44.64 | 25.95 | 10196 | 31.65880671 | CS |
156 | 4.72 | 17.5922474842 | 26.83 | 44.64 | 19.45 | 8020 | 30.16840193 | CS |
260 | -30.529411 | -49.1779971946 | 62.079411 | 95.96 | 17.61 | 6189 | 30.10797516 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관